Clinical, immunologic, molecular analyses and outcomes of iranian patients with <scp>LRBA</scp> deficiency: A longitudinal study
-
- Gholamreza Azizi
- Department of Laboratory Medicine Imam Hassan Mojtaba Hospital Alborz University of Medical Sciences Karaj Iran
-
- Hassan Abolhassani
- Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences Tehran Iran
-
- Seyed Alireza Mahdaviani
- Pediatric Respiratory Diseases Research Center National Research Institute of Tuberculosis and Lung Diseases (NRITLD) Shahid Beheshti University of Medical Sciences Tehran Iran
-
- Zahra Chavoshzadeh
- Pediatric Infections Research Center Mofid Children Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
-
- Peyman Eshghi
- Pediatric Congenital Hematologic Disorders Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
-
- Reza Yazdani
- Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences Tehran Iran
-
- Fatemeh Kiaee
- Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences Tehran Iran
-
- Mohammadreza Shaghaghi
- Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences Tehran Iran
-
- Javad Mohammadi
- Department of Biomedical Engineering Faculty of New Sciences and Technologies University of Tehran Tehran Iran
-
- Nima Rezaei
- Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences Tehran Iran
-
- Lennart Hammarström
- Division of Clinical Immunology Department of Laboratory Medicine Karolinska Institute at Karolinska University Hospital Huddinge Stockholm Sweden
-
- Asghar Aghamohammadi
- Research Center for Immunodeficiencies Children's Medical Center Tehran University of Medical Sciences Tehran Iran
抄録
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p><jats:styled-content style="fixed-case">LPS</jats:styled-content>‐responsive beige‐like anchor protein (<jats:styled-content style="fixed-case">LRBA</jats:styled-content>) deficiency is a combined immunodeficiency caused by mutation in <jats:italic><jats:styled-content style="fixed-case">LRBA</jats:styled-content></jats:italic> gene. The patients have a variety of clinical symptoms including hypogammaglobulinemia, recurrent infections, autoimmunity, and enteropathy.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A total of 17 <jats:styled-content style="fixed-case">LRBA</jats:styled-content>‐deficient patients were enrolled in this longitudinal study. For all patients, demographic information, clinical records, laboratory, and molecular data were collected.</jats:p></jats:sec><jats:sec><jats:title>Result</jats:title><jats:p>Hypogammaglobulinemia was reported in 14 (82.4%), <jats:styled-content style="fixed-case">CD</jats:styled-content>4<jats:sup>+</jats:sup> T‐cell deficiency in five (29.4%), <jats:styled-content style="fixed-case">NK</jats:styled-content> cell deficiency in three (21.4%), and <jats:styled-content style="fixed-case">CD</jats:styled-content>19<jats:sup>+</jats:sup> B‐cell deficiency in 11 (64.7%) patients. All patients had history of infectious complications; pneumonia was the most common (76.5%) occurring infection. A history of lymphoproliferative disorders was observed in 14 (82.3%), enteropathy in 13 (76.5%), allergic symptoms in six (35.5%), neurologic problems in four (23.5), and autoimmunity (mostly autoimmune cytopenia) in 13 (76.5%) patients. Sirolimus treatment improved enteropathy of patients with remarkable success. The 20‐year overall survival rate declined to 70.6%.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p><jats:styled-content style="fixed-case">LRBA</jats:styled-content> deficiency has a very broad and variable phenotype and should be considered, especially in children with early‐onset hypogammaglobulinemia, severe autoimmune manifestations, enteropathy, lymphoproliferation, and recurrent respiratory tract infections.</jats:p></jats:sec>
収録刊行物
-
- Pediatric Allergy and Immunology
-
Pediatric Allergy and Immunology 28 (5), 478-484, 2017-06-19
Wiley